Betta Pharmaceuticals Co., Ltd.

Informe acción SZSE:300558

Capitalización de mercado: CN¥20.7b

Betta Pharmaceuticals Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Lieming Ding

Chief Executive Officer (CEO)

CN¥2.9m

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEO11.3yrs
Participación del CEO0.2%
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directiva5yrs

Actualizaciones recientes de la dirección

Recent updates

We Think That There Are Some Issues For Betta Pharmaceuticals (SZSE:300558) Beyond Its Promising Earnings

Nov 04
We Think That There Are Some Issues For Betta Pharmaceuticals (SZSE:300558) Beyond Its Promising Earnings

Betta Pharmaceuticals Co., Ltd.'s (SZSE:300558) P/E Is Still On The Mark Following 29% Share Price Bounce

Sep 30
Betta Pharmaceuticals Co., Ltd.'s (SZSE:300558) P/E Is Still On The Mark Following 29% Share Price Bounce

Results: Betta Pharmaceuticals Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Aug 07
Results: Betta Pharmaceuticals Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Unpleasant Surprises Could Be In Store For Betta Pharmaceuticals Co., Ltd.'s (SZSE:300558) Shares

Jul 30
Unpleasant Surprises Could Be In Store For Betta Pharmaceuticals Co., Ltd.'s (SZSE:300558) Shares

These 4 Measures Indicate That Betta Pharmaceuticals (SZSE:300558) Is Using Debt Reasonably Well

Jul 05
These 4 Measures Indicate That Betta Pharmaceuticals (SZSE:300558) Is Using Debt Reasonably Well

Betta Pharmaceuticals' (SZSE:300558) Earnings Are Weaker Than They Seem

Apr 26
Betta Pharmaceuticals' (SZSE:300558) Earnings Are Weaker Than They Seem

Earnings Miss: Betta Pharmaceuticals Co., Ltd. Missed EPS By 6.1% And Analysts Are Revising Their Forecasts

Apr 23
Earnings Miss: Betta Pharmaceuticals Co., Ltd. Missed EPS By 6.1% And Analysts Are Revising Their Forecasts

What Betta Pharmaceuticals Co., Ltd.'s (SZSE:300558) P/E Is Not Telling You

Apr 16
What Betta Pharmaceuticals Co., Ltd.'s (SZSE:300558) P/E Is Not Telling You

CEO

Lieming Ding (61 yo)

11.3yrs

Permanencia

CN¥2,900,800

Compensación

Dr. Lieming Ding founded Betta Pharmaceuticals Co., Ltd.(also known as Zhejiang BetaPharma Co., Ltd) in 2002 and serves as its Chairman. Dr. Ding has been Chief Executive Officer and General Manager of Bet...


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Lieming Ding
Founderno dataCN¥2.90m0.24%
CN¥ 48.7m
Jianxun Fan
VP, CFO & Directorno dataCN¥1.46m0.031%
CN¥ 6.4m
Jiang Wan
Senior VP5yrsCN¥2.55m0.025%
CN¥ 5.2m
Jia Tong
Directorno dataCN¥1.46m0.039%
CN¥ 8.1m
Wei Wang
Independent Director5yrsCN¥120.00ksin datos
Cai Jiangnan
Independent Director5yrsCN¥120.00ksin datos
Yangnan Zhang
Chairman of the Supervisory Board & Senior Director of Project Declaration5yrsCN¥870.70ksin datos
Zhihua Yu
Director5yrssin datossin datos
Tian Xu
Director2.1yrssin datossin datos
Fei Wu
Supervisorno dataCN¥860.20ksin datos
Jiajia Xiao
Independent Director2.1yrsCN¥120.00ksin datos
Rong Wang
Shareholder Supervisor1.9yrssin datossin datos

5.0yrs

Permanencia media

56.5yo

Promedio de edad

Junta con experiencia: La junta directiva de 300558 se considera experimentada (5 años de antigüedad promedio).